ArticleInternational journal of heart failure2024

The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series.

Taeil Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.